A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...

Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

Posters presented at the 2025 American Academy of Dermatology Annual Meeting found bimekizumab to have benefits beyond safety ...

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

Results from multiple Phase III trials of Icotrokinra in moderate-to-severe plaque psoriasis and a Phase IIb trial in ...

Researchers studied the relationship between 3 dermatological immune-mediated inflammatory diseases and COVID-19.

Discover how psoriasis affects immune function and the role of SSAT1 in this chronic skin condition. Learn more now.

Adults and adolescents treated with icotrokinra experienced improvements in their moderate to severe plaque psoriasis, ...